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Chylopericardium Secondary to Lymphangiomyoma
− A case report −
Seongmin  Ko,  M.D.*,  Yang-Haeng  Lee,  M.D.*,  Kwang-Hyun  Cho,  M.D.*,  Young-Chul  Yoon,  M.D.*, 
Il-Yong  Han,  M.D.*,  Kyung-Taek  Park,  M.D.*,  Soo-Jin  Jung,  M.D.**
Chylopericardium is a rare disease entity characterized by the accumulation of chylous fluid in the pericardial sac. 
It usually arises from mediastinal neoplasms, thrombosis of the subclavian vein, tuberculosis, nonsurgical trauma, 
thoracic or cardiac surgery. The spectrum of symptoms for chylopericardium varies from an incidental finding of 
cardiomegaly to dyspnea, upper abdominal discomfort, cough, chest pain, palpitation, fatigue. However, most of the 
patients are asymptomatic. The main purpose of treatment of chylopericardium is the prevention of cardiac tampo-
nade and prevention of metabolic, nutritional, and immunological compromise due to chyle leak. Here, we report a 
case of chylopercardium secondary to lymphangiomyoma with review of the literature. 
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CASE REPORT
A  37-year-old  woman  visited  the  Division  of  Cardiology, 
Department of Internal Medicine with an incidental finding of 
cardiomegaly  during  a  routine  screening  test  at  her 
workplace.  The  vital  signs  were  stable  with  a  heart  rate  of 
80/min, systolic blood pressure of 100 mmHg, respiratory rate 
of  18/min,  body  temperature  of  37.0
oC.  Echocardiography 
showed  an  ejection  fraction  of  76.4%  with  normal  cardiac 
structures  including  valves.  However,  it  showed  a  moderate 
pericardial  effusion,  and  the  pericardial  effusion  size  was 
measured  at five different points. The diameters were  0.9 cm 
at the anterior site of the right ventricle, 1.5 cm at the poste-
rior site of the left ventricle, 0 .4 cm at th e later al site o f the 
left  ventricle,  0.6  cm  at  the  right  atrial  site,  1.7  cm  at  the 
apex site which was the largest. Other laboratory examination 
findings  were  within  their  normal  ranges.  The  initial  diag-
nosis  was  pericarditis  with  pericardial  effusion.  It  was  de-
cided  to  treat  the  patient  with  oral  diuretics.  After  3  months, 
chest  X-ray  did  not  show  any  improvement  in  cardiac  size, 
and  hence  chest  X-ray  was  followed  by  chest  CT  (computed 
tomography).  A  cystic  mass  in  the  right  cardiophrenic  angle 
having  homogeneous  low  attenuation  and  pericardial  effusion 
without  definite  pericardial  thickening  or  enhancement  were 
d e t e c t e d  ( F i g .  1 ) .  T h e  w o m a n  w a s  t r a n s f e r r e d  t o  t h e  D e p a r t -
ment  of  Cardiothoracic  Surgery  for  surgical  resection  of  the 
cystic  mass  and  confirmation  of  the  diagnosis.  The  operation 
was  performed  by  videoscopically  assisted  right  thoracotomy Seongmin Ko, et al
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Fig. 1. (A) Cystic mass in the right cardiophrenic angle with ho-
mogeneous low attenuation. (B) Pericardial effusion without definite 
pericardial thickening or enhancement.
Fig. 2. (A) The mass is composed of slit-like vascular spaces and remaining lymphoid tissue on low-power view. (B) There are lymphoid 
aggregations suggesting pre-existing lymphoid accumulations (H&E stain, ×10). 
through three trocar holes. The cystic mass was removed and 
pericardiotomy  and  pericardial  biopsy  were  performed.  After 
pericardiotomy,  massive  amount  of  milky  fluid  about  950  cc 
was  drained.  A  sample  of  the  milky  fluid  was  sent  for  labo-
ratory  examination,  and  pericardial  tissue  sample  was  ob-
tained for pathologic examination. After sampling and biopsy, 
the pericardial sac was cleansed with normal saline irrigation. 
Wounds  due  to  trocar  insertion  were  closed  layer  by  layer, 
after  positioning  one  chest  tube  into  the  pericardial  sac,  and 
the  other  into  the  thoracic  cavity.  Laboratory  examination 
findings  of  the  milky  fluid  were  as  follows:  pH  7.5,  RBC 
6,900/mm
3,  WBC  9,700/mm
3,  90%  lymphocyte  dominance  in 
the  differential  WBC  count,  blood  glucose  83  mg/dL,  LDH 
164  U/L, albumin 3.5 gm/dL, triglycerides 1,508 mg/dL.  The 
pathologic  report  of  the  cystic  mass  was  lymphangiomyoma 
and  that  of  the  pericardial  tissue  sample  was  chronic  in-
flammation  (Fig.  2).  Based  on  the  laboratory  examination 
findings and pathologic report, we confirmed the diagnosis of 
chylopericardium  due  to  lymphangiomyoma.  The  chest  tube 
was  removed  from  the  thoracic  cavity  on  the  13th  day  after 
surgery  and  from  the  pericardial  sac  on  the  14th  day  after 
surgery.  The  patient  was  discharged  on  the  15th  day  after 
surgery,  and  was  followed  up  in  the  outpatient  department. 
At  the  3-month  and  1-year  follow-up,  there  were  neither  any 
signs  of  cardiomegaly  nor  of  pericardial  effusion. 
DISCUSSION
Chylopericardium  is  a  rare  disease  entity  characterized  by 
the accumulation of chylous fluid in the pericardial sac. Since 
Hazebrock  first  described  the  term,  chylopericardium  with 
chlyous  fluid  in  the  pericardial  sac  in  1888,  and  Groves  & 
Effler  used  the  term  primary  idiopathic  chylopericardium  in 
1954,  many  suggestions  about  the  etiology  of  chylopericar-
dium  have  been  presented.  However,  the  definite  cause  of 
chylopericardium  has  not  been  established  [1].  Chylopericar-
dium  usually  arises  from  mediastinal  neoplasms,  thrombosis 
of  the  subclavian  vein,  tuberculosis,  nonsurgical  trauma, Chylopericardium 
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thoracic  or  cardiac  surgery  [1].  The  main  mechanism  respon-
sible  for  the  development  of  chylopericardium  is  similar  to 
that  in  chylothorax,  i.e  the  mechanical  obstruction  of  the 
thoracic duct or the disturbances in the drainage of chyle into 
the subclavian vein. The spectrum of symptoms for chyloper-
icardium varies from an incidental finding of cardiomegaly to 
dyspnea,  upper  abdominal  discomfort,  cough,  chest  pain,  pal-
pitation,  fatigue.  However,  most  of  the  patients  are  asympto-
matic  [2].  The  diagnosis  of  chylopericardium  is  made  as  fol-
lows: most cases show cardiomegaly on chest X-ray, and fur-
ther  evaluation  could  be  performed.  The  presence  of  peri-
cardial  effusion  is  usually  diagnosed  with  echocardiography 
or computed tomography. If a pericardial effusion is detected, 
the  characteristics  of  the  pericardial  effusion  should  be  ana-
lyzed  with  pericardiocentesis.  If  the  macroscopic  examination 
of the pericardial effusion shows the presence of a milky flu-
id and the laboratory examination of the milky fluid shows a 
high  level  of  triglycerides,  the  diagnosis  of  chylopericardium 
should be made. The main differential diagnosis of pericardial 
effusion  is  cholesterol  pericarditis,  in  which  the  pericardial 
fluid  contains  cholesterol  crystals,  and  the  macroscopic  ex-
amination mimics that of chylopericardium [3]. The character-
istics  of  the  fluid  are  milky-white  appearance  which  clears 
promptly after addition of ether, presence of fat droplets dem-
onstrated  by  a  Sudan  III  stain,  relatively  high  triglyceride 
content  compared  with  cholesterol,  high  protein  content  and 
predominance of the lymphocytes [2]. If a diagnosis of chylo-
pericardium  is  made,  further  evaluation  should  be  carried  out 
to  detect  any  communication  between  the  lymphatic  channels 
and  the  pericardium  [2].  Direct  lymphangiography  and  radio-
nuclide  lymphangiography  should  be  carried  out  in  such  cas-
es,  however  no  communication  between  the  lymphatic  chan-
nels and the pericardium is detected in most cases. If there is 
any  communication  between  the  lymphatic  channels  and  the 
pericardium,  it  could  demonstrate  a  direct  communication  be-
tween  the  pericardial  sac  and  the  lymphatic  channels  [4]  or 
show pooling of contrast in the pericardial sac [5]. The pres-
ence  of  communication  could  exclude  any  mechanical  obst-
ruction.  This  can  be  very  useful  in  planning  an  operation 
such as thoracic duct ligation. The main purpose of treatment 
of  chylopericardium  are  the  prevention  of  cardiac  tamponade 
and  prevention  of  metabolic,  nutritional,  and  immunological 
compromise due to chyle leak [2]. The therapeutic modalities 
are  as  follows;  pericardiocentesis  for  both  the  diagnostic  and 
therapeutic  purposes,  pericardial  window  formation,  peri-
cardiectomy,  thoracostomy  drainage,  ligation  of  or  resection 
of  the  thoracic  duct  in  the  lower  part  of  the  chest,  dietary 
support  with  medium  or  short-chain  triglycerides  and  low  fat 
meals  [6],  pericardial-peritoneal  shunt  [7].  Although,  chylo-
pericardium  does  not  respond  well  to  the  conservative  treat-
ment,  and  surgical  treatment  is  required  in  most  cases, 
Szabados  et  al.  reported  a  case  treated  with  conservative 
treatment  using  octreotide  [8].  In  this  case,  chylopericardium 
was  associated  with  lymphangiomyoma.  Lymphangiomyoma 
is  characterized  by  a  proliferation  of  lymph  vessels  and 
smooth  muscle  elements.  The  accumulation  of  chylous  fluid 
in  the  pericardial  sac  is  considered  to  be  the  result  of  abnor-
mal proliferation of the lymphatic vessels due to lymphangio-
myoma  in  the  pericardium.  After  surgical  resection  of  the 
lymphangiomyoma,  chest  X-ray  showed  no  cardiomegaly.  If 
any  changes  may  occur  during  follow-up,  an  operation  such 
as  thoracic  duct  ligation  can  be  considered.
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